Share with others who have ER-/PR-/HER2- breast cancer.
Posted on: Jul 29, 2021 03:09PM
Keytruda Before and After Surgery Improves Outcomes in Early-Stage Triple-Negative Breast Cancer
July 27, 2021
The immunotherapy medicine Keytruda plus chemotherapy before surgery and Keytruda alone after surgery improved event-free survival better than chemotherapy alone in women diagnosed with early-stage triple-negative breast cancer. Read more...